Home > Journals > International Angiology > Past Issues > Articles online first > International Angiology 2020 Nov 13



To subscribe PROMO
Submit an article
Recommend to your librarian


Publication history
Cite this article as



International Angiology 2020 Nov 13

DOI: 10.23736/S0392-9590.20.04450-8


language: English

Body dysmorphic disorder in patients with telangiectasias

Javier A. BRAVO 1, Sebastián CIFUENTES 1, Jorge H. ULLOA 2 , Lowell KABNICK 3, Alejandro PEDRAZZOLI 4, Carlos SIMKIN 5, Julian JAVIER 6, Fabricio SANTIAGO 7

1 Universidad de los Andes, Bogotá, Colombia; 2 Fundación Santa Fe de Bogota, Universidad de los Andes, Bogotá, Colombia; 3 Atlantic Health, Morristown Medical Center, NJ, USA; 4 Centro Pedrazzoli, Córdoba, Argentina; 5 Hospital Pedro Fiorito, Buenos Aires, Argentina; 6 Naples Cardiac and Endovascular Center, Naples, FL, USA; 7 Instituto de Doenças venosas e linfáticas, Goiânia, Goiás, Brasil


BACKGROUND: Chronic venous disease (CVD) patients can present with a spectrum of clinical manifestations ranging from severe ulcerations, thrombosis, and varicose vein hemorrhage to milder ones such as telangiectasias. Some CVD patients have a minimal degree of telangiectasias that are almost invisible to the physician. In spite of successful treatment of these telangiectasias, there are patients that might insist on continuing treatment, focusing excessive attention on what they perceive to be persistent telangiectasias that, in their opinion, must be removed. In these cases, one might be facing a possible body dysmorphic disorder (BDD) diagnosis.
METHODS: This is a multicentric study performed in 223 patients with telangiectasias (C1s) seeking treatment; the “Body Dysmorphic Disorder Questionnaire” (BDDQ) was answered in private by all the patients. Furthermore, each questionnaire was evaluated in accordance with the “Diagnostic and Statistical Manual of Mental Disorders” (DSM-V) criteria for BDD.
RESULTS: From a consecutive sample of 223 patients, 38 patients had criteria for BDD according to the DSM-V; indicating that the prevalence of BDD in patients with telangiectasias is 17%.
CONCLUSIONS: Telangiectasias can be a stress trigger that changes the way patients perceive their own appearance. BDD patients tend to focus their attention excessively upon these types of veins and demand unnecessary treatment for minimal telangiectasias in order to diminish their discomfort with their physical appearance. Body dysmorphic disorder occurs in patients with limbs with C1s disease in considerable proportion and, upon evaluation, these patients should be referred to a psychiatrist. The initiation of any treatment for telangiectasias prior to the psychiatric assessment should be avoided.

KEY WORDS: Body dysmorphic disorder; Telangiectasias; Varicose veins

top of page